BINDEMOLEKÜLE FÜR BCMA UND CD3

European patent · EP3611193 · In force

Register entry

Publication number
EP3611193
Application number
EP19196304
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Nov 15, 2012
Published
Feb 19, 2020
Granted
Aug 26, 2026
Protection ends at the latest
Nov 14, 2032
Next annual fee due
Nov 30, 2026
IPC classes
C07K 16/28 (2006.01)
A61K 39/395 (2006.01)
A61P 35/02 (2006.01)
A61P 37/00 (2006.01)
Priority
US 201161560144 P 15.11.2011
US 201161560149 P 15.11.2011
US 201161560162 P 15.11.2011
US 201161560178 P 15.11.2011
US 201161560183 P 15.11.2011
US 201261651486 P 24.05.2012
US 201261651474 P 24.05.2012
Divided from
EP12805432
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Oct 14, 2026

    Change

    Published in Swissreg on 14.10.2026

  2. Sep 30, 2026

    Change

    Published in Swissreg on 30.09.2026

  3. Sep 2, 2026

    Change

    Published in Swissreg on 02.09.2026

  4. Aug 26, 2026

    Granted

    Specification status
    Non-published patent application → Granted patent
    Status of protective title
    Initiated → Active

    Published in Swissreg on 26.08.2026

Parties

Inventor

KUFER, Peter

81477 Munich, DE

RAUM, Tobias

81477 Munich, DE

HOFFMANN, Patrick

81477 Munich, DE

KISCHEL, Roman

81477 Munich, DE

LUTTERBUESE, Ralf

81477 Munich, DE

RAU, Doris

81477 Munich, DE

ADAM, Paul

55216 Ingelheim am Rhein, DE

BORGES, Eric

55216 Ingelheim am Rhein, DE

HEBEIS, Barbara

55216 Ingelheim am Rhein, DE

HIPP, Susanne

55216 Ingelheim am Rhein, DE

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.